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Abstract
A new class of biosurfactants, namely quaternary ammonium sophorolipids (SQAS), suitable for pharmaceutical
applications, was tested for the evaluation of their (anti)estrogenic and (anti)androgenic potency with the help of YES/YAS
assays. Also their toxicity towards yeasts (Saccharomyces cerevisiae) and bacteria (Escherichia coli) was checked. The
results achieved for SQAS, which can be regarded as potential micropollutants, were compared with those obtained for two
well-known micropollutants diclofenac and 17α-ethinylestradiol subjected to the same testing procedures. This work
demonstrated that acetylation of the hydroxyl group of the carbohydrate head of SQAS decreased the toxicity of this class of
biosurfactants towards Saccharomyces cerevisiae. Furthermore, it contributed to the decrease of their endocrine disrupting
potency. None of the SQAS studied showed clear agonist activity for female or male hormones. SQAS1 and SQAS2
revealed weak antiestrogenic and antiandrogenic potency. All of these properties were weaker, not only to the potency of the
appropriate positive control in the antagonists bioassays, but also compared to the potency of other tested compounds, i.e.
DCF and EE2. SQAS3 possessed most probably inhibitory activity towards male hormones. Moreover, cytotoxicity of two
out of four studied SQAS at the highest concentrations towards the strains of Saccharomyces cerevisiae interfered with the
endocrine disruption activity. It would be also worth studying it with the use of another endocrine activity test.
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Introduction
Some natural and synthetic compounds that are able to
interfere with the usual functioning of the endocrine system
in humans and animals are collectively called endocrine
disrupting compounds (EDCs). This group of chemicals
mainly consists of natural and synthetic hormones and their
metabolites, but also several non-steroidal synthetic com-
pounds that are used as plasticizers, flame retardants,
surfactants and pesticides as well as some pharmaceutical and
personal care products (Caliman and Gavrilescu 2009; Hamid
and Eskicioglu 2012). Most of them end up in the sewage
system after use and finally reach the wastewater treatment
plants (WWTPs). Their concentrations in the influent of
WWTPs range usually between 0.1 and 10 μg l−1, so that
these chemicals are called micropollutants (Luo et al. 2014).
A major contributor to the total estrogenicity of municipal
wastewater is the synthetic estrogen 17α-ethinylestradiol
(EE2), which is widely used in contraceptive pills. Apart
from EE2, the highest concentrations in raw municipal
wastewater were reported for potential non-steroidal synthetic
EDCs such as nonylphenol and diclofenac (Janex–Habibi
et al. 2009; Rosal et al. 2010). For example, the reported
concentration of diclofenac varied from below 0.001 to
94.2 μg l−1 (Kasprzyk–Hordern et al. 2009; Stamatis and
Konstantinou 2013; Ruel et al. 2012; Loos et al. 2013; Gao
et al. 2014). The fate of micropollutants in WWTPs depends
on the individual physicochemical and biological properties
of each compound. Ruel et al. (2012) estimated that on
average 80% of the load of micropollutants was removed
by conventional activated sludge systems in WWTPs.
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Micropollutants were usually removed from wastewater as a
result of sorption and/or microbiological degradation. Sorp-
tion onto suspended colloids and particles caused to the
removal of these chemicals via waste sludge. According to
the classification proposed by Luo et al (2014) human
estrogens, EE2, bisphenol A and triclosan were highly
removed from wastewater (degree above 70%); nonylphenol
could be classified as moderately removed (degree from 40 to
70%), while atrazine and diclofenac were poorly removed
(degree below 40%).
The number of chemicals introduced on the market is still
increasing and some of them are classified as environmentally
relevant emerging contaminants (Richardson and Ternes
2018). Therefore, it is required to evaluate their physical,
chemical and biological properties at the early stage of their
life, i.e. before they go into widespread use. Due to thorough
studies on chemical properties, it is easier to predict their fate
and behaviour in the environment and to avoid threats to living
organisms including humans. One of the new classes of che-
micals particularly requiring a full description of biological
properties, is the class of biosurfactants, namely sophorolipid
quaternary ammonium salts.
Sophorolipids are extracellular biosurfactants mainly
biosynthesized by yeasts such as Candida bombicola,
Candida apicola and Starmerella bombicola. They possess
high surface activity, low foaming ability, fast wetting
action and low toxicity. Furthermore, they can be com-
pletely biodegradable. All these features make sophor-
olipids an alternative to petrochemical-based surfactants.
Nevertheless, their application as detergents is limited due
to higher production costs compared to synthetic surfac-
tants. Therefore, other application areas of sophorolipids are
looked for.
Sophorolipids, particularly lactonic sophorolipids exhibit
antimicrobial activity towards Gram-positive and Gram-
negative bacteria (Shah and Badia 2007). Such sophorolipid
derivatives as sophorolipids diacetate ethyl esters were
reported as the most potent spermicidal and virucidal agents
out of those studied by Shah et al. (2005). They also exhibit
cytotoxic effects on selected cancer cells (Jing et al. 2006).
Custom-built biosurfactants with improved performance,
suitable for biomedical applications can be synthesized by
chemical and enzymatic modification (Sajna et al. 2015;
Delbeke et al. 2016).
An innovative modification pathway of sophorolipids
has been described by the Stevens group (Ghent University,
Belgium) leading to a new class of biosurfactants, i.e.
quaternary ammonium sophorolipids (SQAS). It occurred
that some of the new synthesized compounds were more
active against bacteria than the antibiotic gentamicin sulfate.
In this work, four SQAS of different chemical compo-
sition synthesized by Delbeke et al. (2015) were tested. The
criterion of the selection of SQAS was the value of the
minimum inhibitory concentration (MIC) determined in
tests with Gram-positive and Gram-negative bacteria. The
selected SQAS are characterized by minimum inhibitory
concentrations at the same or higher level than that of
gentamicin.
The main aim of this work was to determine the (anti)
estrogenic and (anti)androgenic properties of the repre-
sentatives of the innovative class of biosurfactants (SQAS),
and to compare the results with those obtained for the well-
known micropollutants (diclofenac and 17α-ethinylestra-
diol). Additionally, the toxicity of all tested compounds
towards the pure culture of Escherichia coli was checked.
Materials and methods
Compounds tested
Four innovative SQAS and two common micropollutants
were subjected to tests to determine their endocrine potency
and toxicity in this study. SQAS were synthesized at the
Department of Green Chemistry and Technology (Ghent
University, Belgium). As described in the introduction, the
MIC value was assumed as the criterion for the selection of
SQAS. The synthesis method and physicochemical proper-
ties of the SQAS tested as well as their potential applications
were described elsewhere (Delbeke et al. 2015; Delbeke
et al. 2016). In view of micropollutant behavior, the com-
pounds were compared to diclofenac and 17α-ethinylestra-
diol. They were purchased from Sigma-Aldrich (Sigma-
Aldrich, Germany) and their purity was not lower than 98%.
Chemical names and structures as well as the codes of all
compounds studied are shown in Table 1.
XenoScreen YES/YASTM test
The XenoScreen YES/YASTM test, i.e. the Yeast Estrogen
Screen (YES)/Yeast Androgen Screen (YAS), was used for
the determination of the estrogenic, antiestrogenic, andro-
genic and antiandrogenic potency of the tested compounds.
This test is based on the use of genetically modified strains
of Saccharomyces cerevisiae with DNA sequences of
human estrogen receptor (hERα) or human androgen
receptor (hAR) that were stably incorporated into the yeast
genome (Routledge and Sumpter 1996). Additionally, the
cells contain an expression plasmid carrying the reporter
gene lacZ encoding for the enzyme β-galactosidase and
estrogen (YES) or androgen (YAS) responsive elements
(Routledge and Sumpter 1996; Sohoni and Sumpter 1998).
The activation of the hormone receptors (hERα or hAR)
by the binding of an endocrine active substance leads to the
expression of β-galactosidase. The β-galactosidase is
secreted into the medium and converts the yellow substrate
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chlorophenol red-β-D-galactopyranoside (CPRG) into a red
product, which can be quantified colorimetrically at 570 nm.
Simultaneously, the assay identifies the cytotoxic effects of
the tested compounds on yeast cells. Cytotoxic effects lead
to growth arrest or lysis of the yeast cells used in the tests. It
is measured as a reduction of light scatter at 690 nm.


















[2-(2,6-Dichloroanilin) phenyl]acetic acid 296.16 DCF
17α-ethinylestradiol 296.40 EE2
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The test was carried out according to the instruction
delivered by the manufacturer Xenometrix AG (Switzer-
land). It consisted of six main steps: (1) yeast cultures
preparation, (2) preparations and control experiments (17-β
estradiol (E2) for YES agonists, 4-hydroxytamoxifen (HT)
for YES antagonists, 5α-dihydrotestosterone (DHT) for
YAS agonists and flutamide (FL) for YAS antagonists) and
their transfer to the assay plates, (3) transfer of YES and
YAS yeast cells to the assay plates, (4) incubation of the
assay plates for 48 h at 32 °C in the presence of the substrate
for β-galactosidase on a rotating platform of the orbital
shaker MB100-4A at approximately 100 rpm, (5) reading
the assay plates using a microplate photospectrometer MB-
530 at 570 and 690 nm, (6) calculation and interpretation of
the results towards (anti)estrogenic and (anti)androgenic
activity of the tested samples and their cytotoxicity. The
individual stock solution for each tested compound in
deionized water at the concentration of 10−2 M was pre-
pared. Then, it was added to the wells in order to achieve
the following final concentrations: 3.16·10−8, 1·10−7,
3.16·10−7, 1·10−6, 3.16·10−6, 1·10−5, 3.16·10−5 and 1·10−4
M. Each bioassay was repeated four times.
Based upon the measurement of the absorbance, the
growth factor (G) and induction (IR) ratio were calculated









where A690,S and A570,S are the absorbances of samples
respectively at 690 and 570 nm and A690,N and A570,N are the
absorbances of the solvent control respectively at 690 and
570 nm.
The growth factor is regarded as the endpoint in the
evaluation of cytotoxicity. The value of G less or equal to
0.5 indicates on possible cytotoxic effects of the compound
tested to the yeast cells.
In order to evaluate the results, the criterion was adopted
that the tested sample has agonistic YES/YAS properties if
the value of IR ≥ 1.5 (for control solutions) and has antag-
onistic YES/YAS properties if the value of IR ≤ 66.7 % of
the value obtained for the control sample (Szczepańska
et al. 2018). It was called the IR criterion in this work.
The values of estrogen equivalent (EEQ) and androgen
equivalent (AEQ) were calculated. They correspond to the
concentration of E2 and DHT, respectively, which would
give the same activity as the sample tested. The calcula-
tions were made if the equivalent concentration was not
lower than 10−10 M in the YES tests or 10−9 M in the YAS
tests. For antiestrogenic and antiandrogenic potency, these
equivalent concentrations were called aEEQ or aAEQ,
respectively.
Additionally, the values of the effective concentrations
(EC50) were determined. In the agonist assays EC50 means
the effective concentration at 50% of IR,MAX, where IR,MAX
is the highest IR of the compound at a non-toxic con-
centration. At the same time in the antagonist assay, the
value of EC50 was calculated only if the percentage of IR,
MIN relative to the fitted IR was equal or lower than 50%,
where IR,MIN is the lowest IR at the non-toxic concentration
of the compound tested.
Determination of toxicity towards Escherichia coli
In order to determine the toxicity of the compounds tested
towards bacteria, the ToxTrakTM method was applied. This
method is based on the reduction of resazurin, a redox-active
dye, by bacterial respiration. When it is reduced, resazurin
changes color from blue to pink. Toxic substances can inhibit
the rate of resazurin reduction, what can be measured color-
imetrically. The endpoint of the ToxTrakTM method is the
inhibition of the bacterial respirometric activity expressed as
the degree of inhibition (%). In agreement with the guidelines
of the manufacturer, it was assumed that the degree of inhi-
bition equal to 10% correlates with the Lowest Observable
Effect Concentration (LOEC).
In this work, the ToxTrakTM test was used to measure the
toxicity of the compounds tested towards the pure culture of
bacteria Escherichia coli DSM 30083. Each of the compounds
was tested individually. The absorbance was measured with the
use of a spectrophotometer DR 6000 at λ= 603 nm. The test
was made in accordance to the guidelines for ToxTrakTM
(Toxicity ToxTrakTM Method 10017, HACH LANGE manual.
https://www.hach.com/toxtrak-reagent-pk-50-powder-pillows/
product-parameter-reagent?id=7640273472&callback=qs).
Each sample was analyzed in four replicates.
Results and discussion
In this work (anti)estrogenic and (anti)androgenic properties of
the chemicals were evaluated with the use of two criteria.
These were the EC50 values (Table 2) and the relation
between the IR of the tested sample and the control sample,
together with the values of the equivalent concentrations
(Table 3). If any compound revealed agonistic or antagonistic
endocrine activity according to the IR criterion it was indicated
by the sign “+” in Table 3. If not, the sign “–” was used.
Estrogenic and androgenic activities
It was found that none of the newly synthesized bio-
surfactants (SQAS) exhibited agonistic properties in relation
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to either estrogenic or androgenic hormonal activities
(Tables 2 and 3). In the case of two SQAS, namely SQAS1
and SQAS2 this was confirmed by both criteria used in this
work (Tables 2 and 3). At the same time the other two
biosurfactants (SQAS3 and SQAS4) showed agonistic
properties related to the male hormone according to the IR
criterion (Table 3). However, the values of equivalent
concentrations (AEQ) could not be determined for SQAS3
and SQAS4 with respect to their agonistic androgen activ-
ity. The problems with the determination of the equivalent
concentrations and the values of EC50 were most probably
connected with the cytotoxicity of SQAS3 and SQAS4
towards YAS yeast cells at the two highest concentrations
tested. The toxicity trumped the endocrine disruption
activity, and therefore it is difficult to judge, whether
SQAS3 and SQAS4 can be classified as androgen agonists.
The cytotoxicity of SQAS also contributed to some
problems to achieve the highest degrees of correlation of the
experimental points to the sigmoidal dose-response curve.
The values of the degree of correlation (R2) were usually
lower in the experiments with SQAS than in these with
DCF or EE2 (Table 2). However, they were at the similar
level to those determined by Czernych et al. (2017) for the
results of the same tests (YES/YAS tests). What is more
important, for all controls the values of R2 were from 0.966
to 0.994 (Table 2), which indicated on the correctness of the
performed bioassays.
With regard to the second group of chemicals tested, i.e.
the common micropollutants (DCF and EE2), it was found
that each of them possessed agonistic activity towards
female hormones. It was confirmed by both criteria used in
this study. The EC50 values determined for EE2 and DCF
were, respectively, four and six orders of magnitude, higher
compared to the value of EC50 obtained for the E2 control,
i.e. 2.12·10−10 M (Table 2). It indicated that EE2 and DCF
were significantly less potent to activate the estrogen
Table 3 (Anti)estrogenic and (anti)androgenic activities of the compounds tested based upon the IR criterion. The values of the equivalent
concentrations
Compound Estrogenic activity Androgenic activity






IR criterion EEQ [M] IR criterion aEEQ [M] IR criterion AEQ [M] IR criterion aAEQ [M]
SQAS1 – <10−10 – 8.67·10−4 – <10−9 – <10−9
SQAS2 – <10−10 – 5.1·10−4 – <10−9 – 8.23·10−2 ± 0.02
SQAS3 – <10−10 – <10−10 + <10−9 + <10−9
SQAS4 – <10−10 – <10−10 + <10−9 – <10−9
DCF + 1.19·10−6 + 1.8·10−1 ± 0.25 – <10−9 + <10−9
EE2 + 3.9·10−5 ± 0.82·10−5 + 8.3·10−2 ± 0.14 – <10−9 + 5.29 ± 5.10
“+” indicates on agonistic or antagonistic endocrine activity according to the IR criterion; “−” indicates on neither agonistic nor antagonistic
endocrine activity according to the IR criterion
Table 2 Values of the effective concentration (EC50) assessed for the
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receptor than E2. Also the results shown in Table 3 con-
firmed that DCF and EE2 were able to activate the estrogen
receptor, and thus have been classified as xenoestrogens.
EE2 is a synthetic estrogen hormone and its hormonal
potency was many times verified in the estrogenic/andro-
genic bioassays in order to check the correctness and/or to
optimize these assays (Ternes et al. 1999; Bistan et al. 2012).
Antiestrogenic and antiandrogenic activities
Regarding the antagonistic (inhibiting) activities of the
compounds tested to the hormone receptors, the following
observations were made.
With respect to the antiestrogenic activity the EC50 values
were obtained for two SQAS, DCF and EE2 (Table 2). Among
the SQAS, SQAS1 and SQAS2 revealed antiestrogenic
potential, however it was significantly lower (three and four
orders of magnitude, respectively) than that determined for the
4-HT control, for which the EC50 value was equal to
0.0692·M. It was also lower than the antiestrogenic activity
found for DCF and EE2 (Table 2). It should be noticed that the
EC50 values for SQAS1 and SQAS2 were extrapolated and
their antiestrogenic potency was not confirmed by the IR cri-
terion (Table 3). At the same time DCF and EE2 revealed
antiestrogenic activity but at the highest tested concentration
tested. Nevertheless, it indicated that they can interact both as
agonists and antagonists with the human estrogen receptor.
The study of the antiandrogenic activity, in particular the
EC50 values, demonstrated that three out of six compounds
studied exerted significant inhibitory effect comparable or
exceeding the inhibitory activity of the positive control, i.e.
FL. It was clearly observed for SQAS3, DCF and EE2
(Table 2). In the case of SQAS1 and SQAS2, the EC50
values were respectively one and two orders of magnitude
higher than that determined for FL (EC50= 6.78·10−6 M
for FL) indicating a much weaker inhibitory effect com-
pared to FL (Table 2). At the same time the strongest
inhibitory properties were found for SQAS3 and DCF. The
EC50 values determined for these compounds were
respectively 10-fold and 100-fold, lower than the EC50
value calculated for FL (Table 2). The antiandrogenic
potency of SQAS3 and DCF was also confirmed by the IR
criterion (Table 3). Regarding SQAS4 it was found that this
compound revealed no antiandrogenic activity according to
both criteria used (Tables 2 and 3).
EE2 occurred to be an antagonist of androgens as well
(Tables 2 and 3). The observations are in agreement with the
fact that many xenoestrogens demonstrate antiandrogenic
activity (Sohoni and Sumpter 1998). DCF and some of its
metabolites were regarded as estrogenic and antiandrogenic
compounds (Klopčič et al. 2018). In this work estrogenic
activity of EE2 and DCF was primarily reported. Never-
theless, it occurred that they can interact both as agonists and
antagonists with the human estrogen/androgen receptors.
This study proves that DCF and EE2 belong to hormone-
mimicking chemicals of multiple hormonal activities.
Toxicities towards yeast cells and Escherichia coli
Simultaneously with the determination of the (anti)estrogenic
and (anti)androgenic activity of the compounds tested, their
cytotoxicity to the strains of Saccharomyces cerevisiae was
measured. The values of growth factor for YES and YAS
yeast cells are depicted in Fig. 1. Based upon them it was
found that all SQAS exerted cytotoxic effects towards cells of
any of the genetically modified YES or YAS yeast strains,
whereas DCF and EE2 did not show any cytotoxic properties
(Fig. 1). SQAS3 and SQAS4 exerted toxic effects towards
both YES and YAS yeast cells at two highest concentrations
tested (G ≤ 0.5), while SQAS1 and SQAS2 were toxic towards
YAS yeast cells only at the highest concentration tested (G ≤
0.5). It shows that SQAS1 and SQAS2 were less toxic
towards the strains of Saccharomyces cerevisiae than SQAS3
and SQAS4. The most likely reason of this behavior of SQAS
is the acetylation of the hydroxyl groups of the carbohydrate
head in the case of SQAS1 and SQAS2 (Table 1). It decreases
the cytotoxicity of this class of biosurfactants and contributes
to the decrease of their endocrine potency as well.
The toxicity of the studied chemicals towards bacteria
Escherichia coli was evaluated using the LOEC as esti-
mator. The values of LOEC varied from 1.07·10−4 to
3.37·10−4 M and despite the difference between them, it
should be noticed that all represent the same order of
magnitude (Fig. 2). It was found that SQAS3 and SQAS4
might exert a stronger effect on the respiration activity of
E. coli than the other compounds tested. Regarding the
chemical structure of SQAS tested, it occurred that the
acetylation of the hydroxyl groups of the carbohydrate head
of SQAS caused a decrease of toxicity towards E. coli as
well. Delbeke et al. (2015) reported that the MIC values for
the studied SQAS ranged between 5·10−6 and 8·10−6 M
towards the following bacteria Bacillus subtilis, Staphylo-
coccus aureus, Enterococcus faecium and Streptococcus
pneumoniae. The lower MIC values indicating a higher
toxicity were found for SQAS3 and SQAS4 in comparison
to SQAS1 and SQAS2 (Delbeke et al. 2015). The results
obtained in this work for SQAS towards E. coli are con-
sistent with findings of Delbeke et al. (2015). Out of all
biosurfactants studied here SQAS2 turned to be the least
toxic followed by SQAS1, SQAS3 and SQAS4 (Fig. 2).
Moreover, it was found that DCF showed relatively
strong, actually stronger than EE2, impact on the bio-
chemical activity of bacteria (Fig. 2), while it did not inhibit
the growth of the yeasts used in the YES/YAS assays. It
proved that the effect of the same compound depended on
the sensitivity of the organism which was exposed to it.
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Fig. 2 Effect of SQAS, DCF and EE2 on respiration activity of Escherichia coli
Fig. 1 The values of growth factor for YES yeast cells (top panels) and YAS yeast cells (bottom panels)
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However, the number of data concerning the effect of
SQAS on the organisms is very small and primarily limited
to bacteria and yeasts. It makes the evaluation of the pos-
sible impacts of this class of biosurfactants on the biota
difficult. So before introducing of SQAS to the market, the
ecotoxicity studies should be extended and comprise other
organisms representing different trophic levels.
Conclusions
1. None of SQAS studied is most likely an agonist of
female or male hormones. SQAS3 shows relatively
strong inhibitory activity towards male hormones.
SQAS1 and SQAS2 reveal weak antiestrogenic and
antiandrogenic potency based upon the values of
EC50. Each of these properties is weaker than the
potency of the appropriate positive control in the
antagonists assays but also compared to the potency
of other tested compounds, i.e. DCF and EE2.
2. The unequivocal evaluation of the endocrine potency
of the SQAS studied is not an easy task due to their
toxic effect at the highest concentrations on the strains
of Saccharomyces cerevisiae used in the YES/YAS
assays. Two out of four SQAS, namely SQAS3 and
SQAS4, show cytotoxicity towards both YES and
YAS yeast cells at the two highest concentrations
tested. SQAS1 and SQAS2 are toxic only towards
YAS yeast cells at the highest concentration tested.
3. This work demonstrates that the acetylation of the
hydroxyl groups of the carbohydrate head of SQAS
decreases the toxicity of these biosurfactants towards
Saccharomyces cerevisiae and contribute to the
decrease of their endocrine potency too.
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